行動保健学の世界市場：2025年～2033年

行動保健学の世界市場は、2024年に637億3,000万米ドルに達し、2033年には1,236億8,000万米ドルに達すると予測され、予測期間2025年～2033年のCAGRは7.5%で成長する見込みです。

世界の行動保健学市場は、うつ病、不安障害、薬物乱用などのメンタルヘルス障害の増加により拡大しています。認知度の向上と偏見の減少により、サービスに対する需要が増加しています。政府のイニシアチブ、資金援助、政策改革が市場の成長を後押ししています。遠隔医療やデジタル治療プラットフォームがアクセシビリティを向上させ、個別化治療や投薬管理などの治療オプションの進歩が市場拡大に寄与しています。従業員の精神的な健康を重視する企業や、プライマリー・ヘルスケアの設定に行動保健学サービスを統合することが、さらに需要を後押ししています。

例えば、米国国立衛生研究所（NIH）の報告によると、米国では578億人の成人が何らかの精神疾患に罹患しており、その重症度は人によって異なります。精神疾患のために日常業務をこなし、障害者認定を受けることができる人もいます。これらの統計を理解することで、認知度を高め、必要としている人々に支援を提供することができます。

世界の行動保健学市場は、メンタルヘルス専門家の不足という大きな課題に直面しています。うつ病、不安神経症、薬物乱用などのメンタルヘルス疾患の有病率の上昇により、メンタルヘルス・サービスに対する需要が急増しています。しかし、訓練を受けた専門家の数が限られているため、需要と供給の間にギャップが生じ、その結果、長い待ち時間、診断の遅れ、不十分な治療がもたらされています。この不足は、特に農村部や十分なサービスを受けていない地域において深刻であり、市場の成長を制限し、メンタルヘルス教育と訓練プログラムへの投資の必要性が拡大しています。

当レポートでは、世界の行動保健学市場について調査し、市場の概要とともに、障害タイプ別、サービスタイプ別、年齢層別、エンドユーザー別、地域別動向、競合情勢、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 調査手法と範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
  • 抑制要因
  • 機会
  • 影響分析

第5章 戦略的洞察と業界の展望

• 市場のリーダーと先駆者
• CXOの視点
• 最新の開発とブレークスルー
• ケーススタディ/進行中の調査
• 規制と償還の情勢
• ポーターのファイブフォース分析
• サプライチェーン分析
• 特許分析
• SWOT分析
• アンメットニーズとギャップ
• 市場参入と拡大のための推奨戦略
• シナリオ分析ベストケース、ベースケース、ワーストケースの予測
• 価格分析と価格動向
• キーオピニオンリーダー

第6章 障害タイプ別

• うつ
• 不安障害
• 双極性障害
• 薬物乱用障害
• 摂食障害
• 注意欠陥多動性障害（ADHD）
• 心的外傷後ストレス障害（PTSD）
• その他

第7章 サービスタイプ別

• 入院治療
• 外来カウンセリング
• 在宅治療サービス
• 緊急メンタルヘルスサービス
• その他

第8章 年齢層別

• 小児
• 病気の診断
• 麻酔モニタリング
• 睡眠モニタリング
• その他

第9章 エンドユーザー別

• 病院・クリニック
• 地域メンタルヘルスセンター
• リハビリテーションセンター
• 住宅治療センター

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他
• 南米
  • ブラジル
  • アルゼンチン
  • その他
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他
• 中東・アフリカ

第11章 競合情勢

第12章 企業プロファイル

• Acadia Healthcare Company, Inc
• Universal Health Services, Inc
• Magellan Health, Inc
• Behavioral Health Network, Inc
• CareTech Holdings PLC
• Centene Corporation
• Pyramid Healthcare, Inc
• Bright Harbor Healthcare
• Behavioral Health Services, Inc
• Similar data will be provided for each market player.
• Strategic Behavioral Health
• North Range Behavioral Health
• Ocean Mental Health Services, Inc.
• The MENTOR Network

第12章 付録

The Global Behavioral Health Market reached US$ 63.73 Billion in 2024 and is expected to reach US$ 123.68 Billion by 2033, growing at a CAGR of 7.5% during the forecast period 2025-2033.

Behavioral health is the study of an individual's behavior, emotions, and mental health, encompassing treatment and management of mental health disorders, substance abuse, and emotional health concerns. It involves interventions like therapy, counseling, medication management, and psychiatric treatments to improve an individual's psychological and emotional state, enabling them to cope with stress, work productively, and maintain healthy relationships. With global awareness of mental health, it is an essential healthcare component.

Market Dynamics: Drivers & Restraints

Rising Prevalence of Mental Health Disorder

The global behavioral health market is expanding due to the rise in mental health disorders like depression, anxiety, and substance abuse. Increased awareness and reduced stigma have led to increased demand for services. Government initiatives, funding, and policy reforms have boosted market growth. Telehealth and digital therapy platforms have improved accessibility, and advancements in treatment options like personalized therapies and medication management are contributing to market expansion. Corporate focus on employee mental well-being and integration of behavioral health services into primary healthcare settings further drives demand.

For instance, according to The National Institutes of Health (NIH) reports that 57.8 Billion adults in the United States suffer from some form of mental illness, with severity varying from person to person. Some individuals can perform daily tasks and qualify for disability due to their mental illness. Understanding these statistics can increase awareness and provide support to those in need.

Lack of Mental Health Professionals

The global behavioral health market faces a significant challenge due to a shortage of mental health professionals. The rising prevalence of mental health disorders like depression, anxiety, and substance abuse has led to a surge in demand for mental health services. However, the limited number of trained professionals creates a gap between demand and supply, resulting in long waiting periods, delayed diagnoses, and inadequate treatment. This shortage is particularly severe in rural and underserved regions, limiting the market's growth and highlighting the need for investment in mental health education and training programs.

Segment Analysis

The global Behavioral Health market is segmented based on Disorder Type, Service Type, Age Group, End User and Region.

Disorder Type:

Depression segment is expected to dominate the Behavioral Health market share

The depression segment holds a major portion of the Behavioral Health market share and is expected to continue to hold a significant portion of the Behavioral Health market share during the forecast period.

Depression is a prevalent mental health disorder worldwide, driving the behavioral health market. The increasing number of individuals affected by depression has led to increased demand for mental health services. Depression often requires counseling, medication, and long-term support, expanding outpatient and inpatient services. Government and non-profit campaigns have encouraged individuals to seek professional help. Healthcare providers and market players are developing innovative treatment approaches, digital mental health solutions, and teletherapy platforms to meet this demand.

For instance, in January 2025, Carisk Partners, a specialty risk transfer and care coordination company, has launched an enhanced Behavioral Health program, leveraging Carisk Behavioral Health and HeadsUp Healthcare's synergies. This strategic expansion aims to improve access to behavioral health services and address lower acuity conditions, including those outlined in New York's Workers' Compensation law.

Serivce Type:-

Inpatient Hospital Treatment segment is the fastest-growing segment in Behavioral Health market share

The inpatient hospital treatment segment is the fastest-growing segment in the Behavioral Health market share and is expected to hold the market share over the forecast period.

Inpatient hospital treatment is crucial in the behavioral health market, especially for patients with severe mental health crises or intensive care needs. Hospitals offer a secure environment for multidisciplinary care, including medication management, psychotherapy, and group counseling. The demand for inpatient mental health services has increased due to complex cases and emergency psychiatric interventions. Healthcare providers are expanding their facilities and investing in specialized units to meet this growing demand, contributing to the market's growth.

For instance, in January 2025, the Regional Mental Hospital has introduced free rTMS therapy for mental health issues, providing painless treatment without anesthesia or prior tests. The machine, which was installed a year ago, will be used for treating depression and obsessive-compulsive disorder, among other conditions.

Geographical Analysis

North America is expected to hold a significant position in the Behavioral Health market share

North America holds a substantial position in the Behavioral Health market and is expected to hold most of the market share due to the increasing prevalence of mental health disorders like depression, anxiety, and substance abuse. Government support, telehealth platforms, and digital therapy solutions have improved access to mental health services, especially in remote areas. The region's emphasis on integrating behavioral health into primary healthcare systems and corporate focus on employee mental well-being continue to drive market growth.

For instance, in January 2024, The U.S. Department of Health and Human Services is launched the Innovation in Behavioral Health (IBH) Model to improve care and outcomes for adults with mental health conditions and substance use disorders. The model aims to connect them with necessary physical, behavioral, and social supports, and promote health IT capacity building through infrastructure payments and other activities. This initiative is part of the Centers for Medicare & Medicaid Services' (CMS) initiative.

Europe is growing at the fastest pace in the Behavioral Health market

Europe holds the fastest pace in the Behavioural Health market and is expected to hold most of the market share due to increased mental health awareness campaigns and government initiatives. Countries are reducing stigma and encouraging treatment. The region's healthcare infrastructure and funding support for psychiatric hospitals and counselling services contribute to market expansion. Digital mental health platforms are also enhancing accessibility. The aging population in Europe drives demand for geriatric mental health services, further driving market growth.

Competitive Landscape

The major global players in the Behavioral Health market include Acadia Healthcare Company, Inc, Universal Health Services, Inc, Magellan Health, Inc, Behavioral Health Network, Inc, CareTech Holdings PLC, Centene Corporation, Pyramid Healthcare, Inc, Bright Harbor Healthcare, Behavioral Health Services, Inc and among others.

Key Developments

• In December 2024, Sukoon Health has launched MERA Sukoon, a 24x7 mental health emergency service in Bengaluru, providing immediate assistance to individuals in distress and their families. Launched in March 2024, the service is led by a dedicated team of consultants.
• In October 2024, Athenahealth, a leading provider of network-enabled software and services, has launched athenaOne for Behavioral Health. This innovative solution aims to help Behavioral Health providers deliver coordinated, holistic patient care by integrating Behavioral Health and Primary Care into one solution, ensuring the patient's center of care.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global Behavioral Health market report delivers a detailed analysis with 61 key tables, more than 59 visually impactful figures, and 220 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Disorder Type & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Disorder Type
• 3.2. Snippet by Service Type
• 3.3. Snippet by Age Group
• 3.4. Snippet by End User
• 3.5. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Increasing Prevalence of Neurological Disorders
  • 4.1.2. Restraints
    • 4.1.2.1. Lack of Mental Health Professionals
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Strategic Insights and Industry Outlook

• 5.1. Market Leaders and Pioneers
  • 5.1.1. Emerging Pioneers and Prominent Players
  • 5.1.2. Established leaders with largest selling Brand
  • 5.1.3. Market leaders with established Product
• 5.2. CXO Perspectives
• 5.3. Latest Developments and Breakthroughs
• 5.4. Case Studies/Ongoing Research
• 5.5. Regulatory and Reimbursement Landscape
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia Pacific
  • 5.5.4. Latin America
  • 5.5.5. Middle East & Africa
• 5.6. Porter's Five Force Analysis
• 5.7. Supply Chain Analysis
• 5.8. Patent Analysis
• 5.9. SWOT Analysis
• 5.10. Unmet Needs and Gaps
• 5.11. Recommended Strategies for Market Entry and Expansion
• 5.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
• 5.13. Pricing Analysis and Price Dynamics
• 5.14. Key Opinion Leaders

6. By Disorder Type

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disorder Type
  • 6.1.2. Market Attractiveness Index, By Disorder Type
• 6.2. Depression*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Anxiety Disorders
• 6.4. Bipolar Disorders
• 6.5. Substance Abuse Disorders
• 6.6. Eating Disorders
• 6.7. Attention Deficit Hyperactivity Disorder (ADHD)
• 6.8. Post-Traumatic Stress Disorder (PTSD)
• 6.9. Others

7. By Service Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
  • 7.1.2. Market Attractiveness Index, By Service Type
• 7.2. Inpatient Hospital Treatment *
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Outpatient Counseling
• 7.4. Home-Based Treatment Services
• 7.5. Emergency Mental Health Services
• 7.6. Others

8. By Age Group

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
  • 8.1.2. Market Attractiveness Index, By Age Group
• 8.2. Pediatric *
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Disease Diagnosis
• 8.4. Anesthesia Monitoring
• 8.5. Sleep Monitoring
• 8.6. Others

9. By End User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.1.2. Market Attractiveness Index, By End User
• 9.2. Hospitals & Clinics*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Community Mental Health Centers
• 9.4. Rehabilitation Centers
• 9.5. Residential Treatment Centers

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disorder Type
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.7.1. U.S.
    • 10.2.7.2. Canada
    • 10.2.7.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disorder Type
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.7.1. Germany
    • 10.3.7.2. U.K.
    • 10.3.7.3. France
    • 10.3.7.4. Spain
    • 10.3.7.5. Italy
    • 10.3.7.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disorder Type
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.7.1. Brazil
    • 10.4.7.2. Argentina
    • 10.4.7.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disorder Type
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.7.1. China
    • 10.5.7.2. India
    • 10.5.7.3. Japan
    • 10.5.7.4. South Korea
    • 10.5.7.5. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disorder Type
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
  • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

Key Market Players

• 12.1. Acadia Healthcare Company, Inc*
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio
    • 12.1.2.1. Product Description
    • 12.1.2.2. Product Key Performance Indicators (KPIs)
    • 12.1.2.3. Historic and Forecasted Product Sales
    • 12.1.2.4. Product Sales Volume
  • 12.1.3. Financial Overview
    • 12.1.3.1. Company Revenue's
    • 12.1.3.2. Geographical Revenue Shares
    • 12.1.3.3. Revenue Forecasts
  • 12.1.4. Key Developments
    • 12.1.4.1. Mergers & Acquisitions
    • 12.1.4.2. Key Product Development Activities
    • 12.1.4.3. Regulatory Approvals etc.
  • 12.1.5. SWOT Analysis
• 12.2. Universal Health Services, Inc
• 12.3. Magellan Health, Inc
• 12.4. Behavioral Health Network, Inc
• 12.5. CareTech Holdings PLC
• 12.6. Centene Corporation
• 12.7. Pyramid Healthcare, Inc
• 12.8. Bright Harbor Healthcare
• 12.9. Behavioral Health Services, Inc
• Similar data will be provided for each market player.

Emerging Market Players

• 12.10. Strategic Behavioral Health*
  • 12.10.1. Pipeline Products Description
  • 12.10.2. Product Key Performance Indicators (KPIs)
  • 12.10.3. Key Activities
  • 12.10.4. Market Entry Timelines
  • 12.10.5. Product Penetration Rate
  • 12.10.6. Sales Estimation and Projections
• 12.11. North Range Behavioral Health
• 12.12. Ocean Mental Health Services, Inc.
• 12.13. The MENTOR Network
• Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

12. Appendix

• 12.1 About Us and Services
• 12.2 Contact Us